SCHEMBL3392073

SCHEMBL3392073

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3F)c2cc1OC1CCN(CC#CC=O)CC1

nearest known ligand 0.72

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 3/20 0.72
EGFR P00533 17/20 0.70
RIPK2 O43353 1/20 0.61
RET P07949 1/20 0.61
MET P08581 1/20 0.61
EPHB2 P29323 1/20 0.61
TEC P42680 1/20 0.61
EPHB4 P54760 1/20 0.61
EPHA4 P54764 1/20 0.61
BTK Q06187 1/20 0.61
KCNH2 Q12809 1/20 0.61
TNK1 Q13470 1/20 0.61
RIPK3 Q9Y572 1/20 0.61
FGFR1 P11362 1/20 0.60
FLT1 P17948 1/20 0.60
KDR P35968 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3389179 0.96 EGFR (0.68) ERBB2EGFRFGFR1FLT1KDR
SCHEMBL4887398 0.85 ERBB2 (0.86) ERBB2EGFRRIPK2RETMET
SCHEMBL3390827 0.85 ERBB2 (0.78) ERBB2EGFRRIPK2RETMET
Hydrochloric Acid SCHEMBL4876811 0.84 ERBB2 (0.85) ERBB2EGFRRIPK2RETMET
SCHEMBL3434900 0.84 EGFR (0.62) ERBB2EGFREPHB4FGFR1FLT1
SCHEMBL4887927 0.84 ERBB2 (1.00) ERBB2EGFRRIPK2RETEPHB2
SCHEMBL3391929 0.84 EGFR (0.73) ERBB2EGFRRIPK2RETMET
SCHEMBL5207429 0.83 EGFR (0.85) ERBB2EGFRRIPK2RETMET
SCHEMBL3391499 0.83 ERBB2 (0.73) ERBB2EGFRRIPK2RETMET
SCHEMBL3395487 0.83 ERBB2 (0.77) ERBB2EGFRRIPK2RETMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2167492-A2 NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS Hanmi Pharm. Co., Ltd. (KR) 2010-03-31 EP disclosed
WO-2008150118-A2 NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS HANMI PHARM. CO., LTD. (KR) 2008-12-11 WO disclosed